Condition: Autosomal Dominant Polycystic Kidney Disease (ADPKD) · Sponsor: Vertex Pharmaceuticals Incorporated
The purpose of the study is to evaluate the effect of VX-407 on height-adjusted total kidney volume (htTKV), safety, tolerability, and pharmacokinetics (PK) of VX-407.
This description comes directly from the study's public registry record.
Medical Information · 617-341-6777 · medicalinfo@vrtx.com
Always discuss trial participation with your own doctor first.
| Alabama Kidney Research | Alabaster, Alabama, United States | Recruiting |
| UAB Nephrology Research at CH19 | Birmingham, Alabama, United States | Recruiting |
| Kaiser Permanente Los Angeles Medical Center | Los Angeles, California, United States | Recruiting |
| UCSF Clinical Research Center at Parnassus | San Francisco, California, United States | Recruiting |
| Nephrology & Hypertension Associates, PC | Middlebury, Connecticut, United States | Recruiting |
| Yale University - Yale Nephrology Clinical Research Clinic | New Haven, Connecticut, United States | Recruiting |
| Mayo Clinic - Jacksonville | Jacksonville, Florida, United States | Recruiting |
| Emory School of Medicine - Renal Division | Atlanta, Georgia, United States | Recruiting |
| Renal Associates | Columbus, Georgia, United States | Recruiting |
| UChicago Medicine - Duchossois Center for Advanced Medicine - Nephrology | Chicago, Illinois, United States | Recruiting |
| University of Iowa Health Care Medical Center- Nephrology | Iowa City, Iowa, United States | Recruiting |
| Clinical & Translational Science Unit (CTSU) - Nephrology | Kansas City, Kansas, United States | Recruiting |
+ 31 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07161037